title: Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response.
authors.affiliation: Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
authors.forename: Andres J
authors.initials: AJ
authors.lastname: Yarur
authors.affiliation: Center for Crohn's and Colitis, Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
authors.forename: Maria T
authors.initials: MT
authors.lastname: Abreu
mesh_terms: D000906:Antibodies / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000493:pharmacokinetics*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D008297:Male; D011247:Pregnancy
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000069285:Infliximab